VALGANCICLOVIR ACCORD 450 mg, film-coated tablet 60 tablets
Active ingredients: Valganciclovir hydrochloride, Valganciclovir
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALGANCICLOVIR ACCORD 450 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 60 comprimé(s)
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Mar 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68011551CIP73007006CIP133400930070062Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALGANCICLOVIRcomprimé | 450 mg · un comprimé | FT |
| CHLORHYDRATE DE VALGANCICLOVIRcomprimé | 496,3 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.